XCancer — Omaha, Nebraska

XCancer is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Clinical Trials Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

XCancer has participated in 8 clinical trials with 6 currently active.

Therapeutic areas: Prostate Cancer, Prostate Cancer Patients With Detectable PSA Following Prostatectomy, Prostate Cancer Recurrent.

Sponsors: Clarity Pharmaceuticals Ltd, Radiopharm Theranostics, Ltd, Fusion Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for XCancer?

XCancer has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has XCancer conducted?

XCancer has 8 clinical trials on record, with 6 currently active. Their work covers Prostate Cancer, Prostate Cancer Patients With Detectable PSA Following Prostatectomy, Prostate Cancer Recurrent.

Is XCancer accredited by Crixeo Clinical Trials?

XCancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about XCancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.